Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer (CHIVA)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01583322 |
Recruitment Status :
Completed
First Posted : April 24, 2012
Last Update Posted : September 6, 2023
|
Sponsor:
ARCAGY/ GINECO GROUP
Information provided by (Responsible Party):
ARCAGY/ GINECO GROUP
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | May 2015 |
Actual Study Completion Date : | March 2016 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):